Učitavanje...
Evolving Treatment Paradigm in Metastatic Renal Cell Carcinoma
The treatment paradigm for advanced and metastatic renal cell carcinoma (mRCC) has evolved rapidly since the arrival of targeted therapies and novel immunotherapies. mRCC was previously treated only with cytokines. However, discoveries of mutations affecting the von Hippel-Lindau tumor suppressor ge...
Spremljeno u:
| Izdano u: | Am Soc Clin Oncol Educ Book |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6855178/ https://ncbi.nlm.nih.gov/pubmed/28561652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EDBK_174469 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|